Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 14: 1066730, 2023.
Article in English | MEDLINE | ID: mdl-36875106

ABSTRACT

The emergence of SARS-CoV-2 variants stresses the continued need for broad-spectrum therapeutic antibodies. Several therapeutic monoclonal antibodies or cocktails have been introduced for clinical use. However, unremitting emerging SARS-CoV-2 variants showed reduced neutralizing efficacy by vaccine induced polyclonal antibodies or therapeutic monoclonal antibodies. In our study, polyclonal antibodies and F(ab')2 fragments with strong affinity produced after equine immunization with RBD proteins produced strong affinity. Notably, specific equine IgG and F(ab')2 have broad and high neutralizing activity against parental virus, all SARS-CoV-2 variants of concern (VOCs), including B.1.1,7, B.1.351, B.1.617.2, P.1, B.1.1.529 and BA.2, and all variants of interest (VOIs) including B.1.429, P.2, B.1.525, P.3, B.1.526, B.1.617.1, C.37 and B.1.621. Although some variants weaken the neutralizing ability of equine IgG and F(ab')2 fragments, they still exhibited superior neutralization ability against mutants compared to some reported monoclonal antibodies. Furthermore, we tested the pre-exposure and post-exposure protective efficacy of the equine immunoglobulin IgG and F(ab')2 fragments in lethal mouse and susceptible golden hamster models. Equine immunoglobulin IgG and F(ab')2 fragments effectively neutralized SARS-CoV-2 in vitro, fully protected BALB/c mice from the lethal challenge, and reduced golden hamster's lung pathological change. Therefore, equine pAbs are an adequate, broad coverage, affordable and scalable potential clinical immunotherapy for COVID-19, particularly for SARS-CoV-2 VOCs or VOIs.


Subject(s)
COVID-19 , SARS-CoV-2 , Cricetinae , Animals , Horses , Humans , Mice , Rodentia , Mesocricetus , Antibodies, Monoclonal , Broadly Neutralizing Antibodies , Immunoglobulin G , Mice, Inbred BALB C
2.
Front Microbiol ; 13: 927122, 2022.
Article in English | MEDLINE | ID: mdl-35756049

ABSTRACT

Marburg virus (MARV) is one of the principal members of the filovirus family, which can cause fatal hemorrhagic fever in humans. There are currently no prophylactic and therapeutic drugs on the market, and the high pathogenicity and infectivity of MARV make its research highly dependent on biosafety level 4 conditions, severely hindering the development of vaccines and therapies. Therefore, the development of medicines, such as MARV serological diagnosis, vaccines, and therapeutic antibody drugs, urgently needs a safe, convenient, and biosafety level 2 detection method to measure the neutralizing activity of MARV antibodies. To this end, we report a neutralization assay relying on a Rabies virus (RABV) reverse genetic operating system. We constructed infectious clones carrying the eGFP reporter gene and the full length of the original unmodified MARV GP gene. Based on the critical parameters of phylogenetic analysis, recombinant viruses targeting representative strains in the two major MARV lineages were successfully rescued. These pseudoviruses are safe in mice, and their inability to infect cells after being neutralized by antibodies can be visualized under a fluorescence microscope. We tested the system using the neutralizing antibody MR191. MR191 can significantly block the infection of BSR cells with pseudovirus. We compared it with the traditional lentivirus-type pseudovirus system to verify the system's credibility and obtained the same results as reported in the literature. In general, we have established a safe and visualized method for evaluating the neutralizing activity of MARV antibodies. Compared with traditional methods, it has the advantages of convenient operation, short cycle, and low cost. It is a candidate method that can replace actual viruses for a neutralization assay.

3.
Bioresour Technol ; 284: 276-285, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30952055

ABSTRACT

This study investigated the synergistic effects and regulation strategy of multiple factors for improving methane production in sequencing batch dry anaerobic digestion (SBD-AD) using corn stalks (CS) and cow dung (CD). The regulation of the spray frequency (SF) and inoculum content (IC) significantly improved methane yield, which increased feedstock ratios (FRs) by 12.4-121.3%. Moreover, the relationship between SF and IC produced distinct interaction modes. An FR of 4:6 increased the SF to 2 h for the CD-rich condition, and an FR of 6:4 decreased the SF during a 6 h interval and increased the IC for the CS-rich condition, resulting in increases in methane yield and the conversion efficiency of volatile fatty acids (VFAs). Methanogenesis (Methanogens) played a key role in SBD-AD. The nutrient substrate (NH4-N+) and key enzyme activities of methanogens were significantly affected such that the synergistic effect of the acetoclastic and hydrogenotrophic methanogenesis pathways was likely strengthened.


Subject(s)
Manure , Methane/biosynthesis , Zea mays/metabolism , Anaerobiosis , Animals , Cattle , Desiccation , Fatty Acids, Volatile/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...